Publication Bias
THE SCIENTIST–Former Head of UK Psychopharmacology says Money Didn’t Sway Dr. Nemeroff
A follow-up to news reports about the conflict of interest scandal that has engulfed not only Dr. Charles Nemeroff, former president and editor in chief of the official journal of the American College of Neuropsychopharmacology, but the College itself.
Read MoreACNP Journal Editor Quits Amid Exposure of Conflicts of Interest
A notice from The American College of Neuropsychopharmacology, the inner sanctum of biological–predominantly drug-centered psychiatry–informs the
membership of the resignation of Dr. Charles Nemeroff, the Editor-in-Chief of its journal, Neuropsychopharmacology.
Lift Veil on Research Funding
A Boston Globe report (below) focuses on three recent reports in the Journal of the American Medical Association (JAMA) by Harvard researchers who violated the journal’s disclosure policy by failing to disclose their financial ties to companies that had the most to gain from their purported findings.
Read MoreJournals Must Exercise Their Authority as Gatekeepers
The harm done by journals’ failure to protect the integrity of science can hardly be overstated.
Read MoreNYT Editorial: Our Conflicted Medical Journals
Today’s New York Times editorial hits the mark–it’s right on target!
Read MoreA Matter of Disclosure: Shame on JAMA editor / Shame on Harvard Scientists / FDA Adds SSRIWarnings
The Associated Press reports (1, 2 below) that the FDA has just issued new warnings about two additional life-threatening risks induced by SSRI antidepressants: Serotonin Syndrome and Persistent Pulmonary Hypertension in newborn babies.
Read MoreIs this the perfect storm of corruption? ACNP journal
The Wall Street Journal and Bloomberg News report about a case involving Neuropsychopharmacology, the official journal of the American College of Neuropsychopharmacology (ACNP) that will likely go down in history as psychiatry’s Watergate.
Read MoreIs this the perfect storm of corruption? ACNP Journal Review VNS
Operating like thieves under the cover of darkness, prominent academic-based "authorities" in medical specialties have debased academic standards and sold their reputations for cash-
Read MoreAssociated Press: JAMA says it was misled by researchers
Following on the heels of an investigative report by David Armstrong of The Wall Street Journal <https://www.ahrp.org/cms/content/view/286/27/> the Associated Press reports that JAMA claims it was misled.
Read MoreCan We Tame the Monster?
"Drug companies should not be allowed to evaluate their own products."
Read MoreJournalism vs. Promotion: TeenScreen–A Study in Contrasts UPI report compared to Washington Post
Compare and contrast two recent news reports about TeenScreen: Lidia Wasowicz of United Press International provides readers with a sense of the controversy generated by psychiatry’s latest market expansion scheme.
Read MoreNEJM Vioxx Safety Correction / Consumers International Accuses Industry–Unscrupulous Marketing
Once again, the New England Journal of Medicine (July 13, 2006) has had to eat crow after it published false and misleading clinical trial findings.
Read More